Filing Details

Accession Number:
0001209191-16-126650
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-08 19:04:05
Reporting Period:
2016-06-06
Filing Date:
2016-06-08
Accepted Time:
2016-06-08 19:04:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365619 Laura Brege C/O Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-06-06 1,000 $46.95 1,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.